Category: Tysabri

Inhibikase Therapeutics Receives Orphan Drug Designation for treatment of Progressive Multifocal Leukoencephalopathy (PML)

ATLANTA, May21, 2014 /PRNewswire/ –Inhibikase Therapeutics, Inc., an emerging developer of products to treat infectious diseases with little or no resistance, announces…

Stuart Schlossman

Multiple Sclerosis Symptom Recrudescence (feeling cruddy) Is Common at the End of the Natalizumab Dosing Cycle

Source: International Journal of MS Care Article Citation:John N. Ratchford, Regina Brock-Simmons, Amanda Augsburger, Sonya U. Steele, Kristie Mohn, Mandi…

Stuart Schlossman

New TYSABRI® Analysis at AAN Annual Meeting Shows Improved Walking Speed in Significant Number of MS Patients

New TYSABRI® Analysis at AAN Annual Meeting  Shows  Improved Walking Speed in Significant Number  of MS Patients Biogen Idec (BIIB) today…

Stuart Schlossman

Understanding The JC Virus Testing

Understanding the JC Virus Test In our pursuit to learn more about PML, a blood test (the JC Virus Test)…

Stuart Schlossman

Multiple Sclerosis: Monoclonal Antibody Tysabri Reduces Brain Inflammation

MedicalResearch.com Interview with:Jeppe Romme Christensen  MD PhDFrom the Danish Multiple Sclerosis CenterCopenhagen University Hospital Hvidovre, Denmark. MedicalResearch.com: What are the…

Stuart Schlossman

HIV Drug May Help in PML

Published: Jan 29, 2014 By John Gever, Deputy Managing Editor, MedPage Today A relatively simple way to make progressive multifocal…

Stuart Schlossman

Antibody Index Test May Aid PML Diagnosis on Natalizumab

Sue Hughes October 30, 2013 COPENHAGEN, Denmark — A new test that compares JC virus (JCV) antibody levels in cerebrospinal fluid (CSF)…

Stuart Schlossman

Test May Suggest Tysabri for More MS Patients

October 7, 2013   COPENHAGEN — A blood test for L-selectin expression on circulating immune cells may identify multiple sclerosis…

Stuart Schlossman

Biogen Idec: New Analyses Show Tysabri Given Earlier Reduces MS Disease Activity

By RTT News,  October 03, 2013 (RTTNews.com) – Biogen Idec ( BIIB ) Thursday announced results from several new analyses of…

Stuart Schlossman

Biogen Idec, Elan facing suits over MS drug side effects

New lawsuit rekindles controversy over rare brain disease linked to multiple sclerosis therapy – Business – The Boston Globe Despite…

Stuart Schlossman

Categories

Latest Blog Posts